利索-全球专利检索

  1. 登录
  2. 注册
发明授权
CN105106228B 用作TMEM16A离子通道激活剂的含人参皂苷Rb1的药物组合物 有权

用作TMEM16A离子通道激活剂的含人参皂苷Rb1的药物组合物
摘要：
本发明用作TMEM16A离子通道激活剂的含人参皂苷Rb1的药物组合物，涉及药物组合物，是由以人参皂苷Rb1为活性成分，辅以药学上可接受的载体组成，所述药学上可接受的载体为淀粉、糖粉、糊精、乳糖、微晶纤维素、甘露醇或其2～6种的混合物，所述活性成分的人参皂苷Rb1与辅以药学上可接受的载体的用量的重量比为1∶0.5～1.5，是一种用于治疗TMEM16A/CaCCs离子通道相关疾病的药物。本发明开发了人参皂苷Rb1的新的药物用途。
摘要（英）：

The invention discloses a medicine composition which is used as a TMEM16A ion channel activator and contains ginsenoside Rb1, and relates to medicine compositions. The medicine composition comprises the ginsenoside Rb1 and auxiliary pharmaceutically acceptable carriers. The ginsenoside Rb1 is an active ingredient, the auxiliary pharmaceutically acceptable carriers include starch, powdered sugar, dextrin, lactose, microcrystalline cellulose, mannitol or mixtures of 2-6 of the starch, the powdered sugar, the dextrin, the lactose, the microcrystalline cellulose and the mannitol, and a weight ratio of the active ingredient, namely, the ginsenoside Rb1, to the auxiliary pharmaceutically acceptable carriers is 1:0.5-1.5. The medicine composition is medicine for treating TMEM16A/CaCCs ion channel related diseases. The medicine composition has the advantage that novel medicine application of the ginsenoside Rb1 is developed.

公开/授权文献
0/0